The mucocutaneous manifestations and pathergy reaction in Behçet's disease

Behçet's Syndrome

Volumn , Issue , 2010, Pages 53-72

  Mat, M Cem ^a   Bang, Dongsik ^b   Melikoǧlu, Melike ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Yonsei University College of Medicine   (South Korea)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acneiform; Beh et's disease; Beh et's syndrome; Cutaneous lesions; Erythema nodosum; Papulopustular; Pathergy; Pseudofolliculitis

Indexed keywords

EID: 84876719419     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5641-5_4     Document Type: Chapter

References (109)

1. Behçet H (1937) Ueber rezidivierende aphtose durch ein virus verursachte geschwuere am mund, am auge und an den genitalien. Dermatol Wochenschr 105:1152
2. Yazici H, Yurdakul S, Hamuryudan V (1998) Behçet's syndrome. In: Maddison PJ, Isenberg DA, Woo P, Glass DN (eds) Oxford textbook of rheumatology, 2nd edn. Oxford University Press, Oxford, pp 1394-1402
3. Zunt SL (2003) Recurrent aphthous stomatitis. Dermatol Clin 21:33-39 (Pubitemid 36255247)
4. Gürler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behçet's disease. An analysis of 2147 patients. Yonsei Med J 38:423-427 (Pubitemid 128516403)
5. Alpsoy E, Dönmez L, Önder M et al (2007) Clinical features and natural course of Behçet's disease in 661 cases. a multicenter study. Br J Dermatol 157:901-906 (Pubitemid 47583484)
6. Saylan T, Mat C, Fresko I, Melikoǧlu M (1999) Behçet's disease in the middle-east. Clin Dermatol 17:209-223
7. Bang D, Hur W, Lee ES, Lee S (1995) Prognosis and clinical relevance of recurrent oral ulceration in Behçet's disease. J Dermatol 22:926-929 (Pubitemid 26031626)
8. McCarthy MA, Garton RA, Jorizzo JL (2003) Complex aphthosis and Behçet's disease. Dermatol Clin 21:41-48
9. Rogers RS I I I (1997) Recurrent aphthous stomatitis in diagnosis of Behçet's disease. Yonsei Med J 38:370-379 (Pubitemid 128516397)
10. Letsinger JA, MacCarty MA, Jorizzo JL (2005) Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide. J Am Acad Dermatol 52:500-508
11. Ifeacho SN, Malhi G, Hamburger M (2004) Recurrent aphtous stomatitis and Behçet's disease: is there a link? XI International Congress on BD. Clin Exp Rheumatol 22(4):101
12. Main DM, Chamberlain MA (1992) Clinical differentiation of oral ulceration in Behçet's disease. Br J Rheumatol 31:767-770
13. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
14. Hamuryudan V, Mat C, Saip S, Ozyazgan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H (1998) Thalidomide in the treatment of the mucocutaneous lesions of the Behçet's syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128(6):443-450
15. Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H (2005) Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. J Rheumatol 32:98-105 (Pubitemid 40092599)
16. Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H (2001) A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 44(11):2686-2692 (Pubitemid 33049346)
17. Cosgun S, Seyahi E, Mat C, Yazici H (2004) Female Behçet's syndrome patients have more severe oral ulceration. XI International congress on Behçet's disease. Clin Exp Rheumatol 22:86
18. Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, Weinberger A (1999) Recurrent aphthous stomatitis in Behçet's disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med 28(5):193-196 (Pubitemid 29188405)
19. Mumcu G, Sur H, Inanc N, Karacayli U, Cimilli H, Sisman N, Ergun T, Direskeneli H (2009) A composite index for determining the impact of oral ulcer activity in Behçet's disease and recurrent aphthous stomatitis. J Oral Pathol Med 38(10):785-791
20. Sharquie KE, Al-Araji A, Hatem A (2002) Oral pathergy test in Behçet's disease. Br J Dermatol 146(1):168-169 (Pubitemid 34158438)
21. Soy M, Erken E, Konca K, Ozbek S (2000) Smoking and Behçet's disease. Clin Rheumatol 19(6):508-509
22. Kaklamani VG, Tzonou A, Markomichelakis N, Papazoglou S, Kaklamanis PG (2003) The effect of smoking on the clinical features of Adamantiades- Behçet's disease. Adv Exp Med Biol 528:323-327
23. Mat C, Goksugur N, Ergin B, Yurdakul S, Yazici H (2006) The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study. Int J Dermatol 45:554-556
24. Bang D, Lee ES, Sohn S (2001) Behçet's disease: a guide to its clinical understanding. Springer, Heidelberg
25. Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Behçet's disease. Yonsei Med J 48:573-585
26. Lee ES, Bang D, LEE S (1997) Dermatologic manifestation of Behçet's disease. Yonsei Med J 38:380-389
27. Lin P, Liang G (2006) Behçet's Disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12:282-286 (Pubitemid 44915326)
28. Kim B, LeBoit PE (2000) Histopathologic features of erythema nodosum-like lesion in Behçet's disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am J Dermatopathol 22:379-390
29. Demirkesen C, Tuzuner N, Mat C, Senocak M, Buyukbabani N, Tuzun Y, Yazici H (2001) Clinicopathologic evaluation of nodular cutaneous lesions of Behçet's syndrome. Am J Clin Pathol 116:341-346 (Pubitemid 32851966)
30. Yazici H, Tüzün Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoǧan H, Serdaroǧlu S, Ersanli M, Ulkü BY, Müftüoǧlu AU (1984) Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 43(6):783-789 (Pubitemid 15190181)
31. Mat CM, Demirkesen C, Melikoglu M, Yazici H (2006) Behçet's syndrome. In: Sarzi-Puttuni P, Doria A, Girolomoni G, Kuhn A (eds) The skin and autoimmune disease. Elsevier, Amsterdam, pp 185-206
32. Kuzu MA, Ozaslan C, Köksoy C, Gürler A, Tüzüner A (1994) Vascular involvement in Behçet's disease: 8-year audit. World J Surg 18(6):948-953
33. Tunc R, Saip S, Siva A, Yazici H (2004) Cerebral venous thrombosis is associated with major vessel disease in Behçet's syndrome. Ann Rheum Dis 63(12):1693-1694 (Pubitemid 39573708)
34. Kucukoglu S, Tunc R, Cetinkaya F, Demirkesen C, Mat C, Yazici H (2000) The importance of cutaneous ultrasonography on the differentiation of nodular skin lesions seen in patients with Behçet's disease. Yonsei Med J 41(3):S40
35. Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, Gaffney K, Mat C, Yazici H, al Ialaan A et al (1995) Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers. J Am Acad Dermatol 32(6):968-976
36. Luelmo-Aguilar J, Santandreu MS (2004) Folliculitis: recognition and management. Am J Clin Dermatol 5(5):301-310 (Pubitemid 39655093)
37. Yazici H, Hekim N, Tüzün Y, Serdaroglu S, Kotogyan A, Öz F, Yurdakul S, Pazarli H, Müftüoǧlu A (1986) Sex factor and Behçet's syndrome. In: Lehner T, Barnes CG, (Eds) Recent advances in Behçet's Disease, Royal Society of Medicine Services, London. pp 205-206
38. Ergun T, Gurbuz O, Dogusoy G, Mat C, Yazici H (1998) Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 37:194-196 (Pubitemid 28140744)
39. Alpsoy E, Aktekin M, Er H, Durusoy C, Yilmaz E (1998) A randomized, controlled and blinded study of papulopustular lesions in Turkish Behçet's patients. Int J Dermatol 37(11):839-842 (Pubitemid 28545277)
40. Kligman AM (1974) An overview of acne. J Invest Dermatol 62(3):268-287
41. Kligman AM (1991) Postadolescent acne in women. Cutis 48(1):75-77
42. Goulden V, McGeown CH, Cunliffe WJ (1999) The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. Br J Dermatol 141(2):297-300 (Pubitemid 29397999)
43. Thiboutot D, Gilliland K, Light J, Lookingbill D (1999) Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol 135(9):1041-1045 (Pubitemid 29430494)
44. Yazici H, Mat C, Deniz S, Iscimen A, Yurdakul S, Tuzun Y, Hekim N, Yazici Y (1987) Sebum production is increased in Behçet's syndrome and even more so in rheumatoid arthritis. Clin Exp Rheumatol 5(4):371-374 (Pubitemid 18027484)
45. Alpsoy E, Elpek GO, Yilmaz F, Ciftcioglu MA, Akman A, Uzun S, Karakuzu A (2005) Androgen receptor levels of oral and genital ulcers and skin pathergy test in patients with Behçet's disease. Dermatology 210(1):31-35 (Pubitemid 39656716)
46. Hatemi G, Bahar H, Uysal S, Mat C, Gogus F, Masatlioglu S, Altas K, Yazici H (2004) The pustular skin lesions in Behçet's syndrome are not sterile. Ann Rheum Dis 63(11):1450-1452 (Pubitemid 39433950)
47. Inanc N, Mumcu G, Birtas E, Elbir Y, Yavuz S, Ergun T, Fresko I, Direskeneli H (2005) Serum mannose-binding lectin levels are decreased in Behçet's disease and associated with disease severity. J Rheumatol 32(2):287-291 (Pubitemid 40209127)
48. Alpsoy E, Uzun S, Akman A, Acar MA, Memişoglu HR, Başaran E (2003) Histological and immunofluorescence findings of non-follicular papulopustular lesions in patients with Behçet's disease. J Eur Acad Dermatol Venereol 17(5):521-524 (Pubitemid 37138888)
49. Ilknur T, Pabuççuoglu U, Akin C, Lebe B, Gunes AT (2006) Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Behçet's disease. Eur J Dermatol 16(2):146-150
50. Kalkan G, Karadag AS, Astarci HM, Akbay G, Ustun H, Eksioglu M (2009) A histopathological approach: when papulopustular lesions should be in the diagnostic criteria of Behçet's disease? J Eur Acad Dermatol Venereol 23(9):1056-1060
51. Boyvat A, Heper AO, Koçyiǧit P, Erekul S, Gürgey E (2006) Can specific vessel-based papulopustular lesions of Behçet's disease be differentiated from nonspecific follicular-based lesions clinically? Int J Dermatol 45(7):814-818 (Pubitemid 43984389)
52. Ergun T, Gürbüz O, Dogusoy G, Mat C, Yazici H (1998) Histopathologic features of the spontaneous pustular lesions of Behçet's syndrome. Int J Dermatol 37(3):194-196 (Pubitemid 28140744)
53. Diri E, Mat C, Hamuryudan V, Yurdakul S, Hizli N, Yazici H (2001) Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study. Ann Rheum Dis 60(11):1074-1076 (Pubitemid 32989185)
54. Lin P, Liang G (2006) Behçet's disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12:282-286 (Pubitemid 44915326)
55. Jung JY, Kim DY, Bang D (2008) Leg ulcers in Behçet's disease. Br J Dermatol 158:172-203
56. Oh SH, Lee JH, Shin JU, Bang D (2008) Dermatological features in Behçet's disease-associated vena cava obstruction. Br J Dermatol 159:555-560
57. Golan G, Beeri R, Mevorach D (1994) Henoch-Schonlein purpura-like disease representing a flare of Behçet's disease. Br J Rheumatol 33:1198-1199
58. Park YW, Park JJ, Lee JB et al (2007) Development of Henoch-Schonlein purpura in a patient with Behçet's disease presenting with recurrent deep vein thrombosis. Clin Exp Rheumatol 25:S96-S98
59. Chen KR, Kawahara Y, Miyakawa S et al (1997) Cutaneous vasculitis in Behçet's disease: a clinical and histopathologic study of 20 patients. J Am Acad Dermatol 36:689-696 (Pubitemid 27215353)
60. Bilic M, Mutasim DF (2001) Neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Cutis 68:107-111 (Pubitemid 33757341)
61. Nijsten TE, Meuleman L, Lambert J (2002) Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Br J Dermatol 147:797-800 (Pubitemid 35286173)
62. Mercader-Garcia P, Vilata-Corell JJ, Pardo-Sanchez J et al (2003) Neutrophilic eccrine hidradenitis in a patient with Behçet's disease. Acta Derm Venereol 83:395-396 (Pubitemid 37281559)
63. Cantini F, Salvarani C, Niccoli L et al (1998) Behçet's disease with unusual cutaneous lesions. J Rheumatol 25:2469-2372
64. Korkmaz C, Aydinli A, Erol N et al (2001) Widespread nocardiosis in two patients with Behçet's disease. Clin Exp Rheumatol 19:459-462 (Pubitemid 32685377)
65. King R, Crowson AN, Murray E et al (1995) Acral purpuric papulonodular lesions as a manifestation of Behçet's disease. Int J Dermatol 34:190-192
66. Aydin F, Senturk N, Yildiz L et al (2006) Behçet's disease with unusual cutaneous lesions. J Eur Acad Dermatol Venereol 20:106-107
67. Callen PR (2007) Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34
68. Magro CM, Crowson AN (1995) Cutaneous manifestations of Behçet's disease. Int J Dermatol 34:159-165
69. Hui-li S, Zheng-ji H (1993) Study on cutaneous lesions in Behçet's disease and meanings of relative laboratory parameters. In: Godeau F, Weschler B (eds) Behçet's disease, Proceedings of the sixth international conference on Behçet's disease. Excerpta Medica, Amsterdam, p 325
70. Oguz A, Serdaroglu S, Tuzun Y, Erdogan N, Yazici H, Savaskan H (1992) Acute febrile neutrophilic dermatosis associated with Behçet's syndrome. Int J Dermatol 31:645-646
71. Azizlerli G, Ozarmagan G, Ovul C, Sarica R, Mustafa SO (1992) A new kind of skin lesion in Behçet's disease: extragenital ulcers. Acta Derm Venereol 72:286
72. Ozarmagan G, Saylan T, Azizlerli G, Ovul C, Aksungur VL (1991) Re-evaluation of the pathergy test in Behçet's disease. Acta Derm Venereol 71:75-76
73. Krause I, Molad Y, Mitrani M, Weinberger A (2000) Pathergy reaction in Behçet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression. Clin Exp Rheumatol 18:71-74 (Pubitemid 30102048)
74. Cakir N, Yazici H, Chamberlain MA, Barnes CG, Yurdakul S, Atasoy S, Akcasu A, Iscimen A (1991) Response to intradermal injection of monosodium urate crystals in Behçet's syndrome. Ann Rheum Dis 50:634-636
75. Yazici H, Tüzün Y, Tanman AB, Yurdakul S, Serdaroglu S, Pazarli H, Müftüoglu A (1985) Male patients with Behçet's syndrome have stronger pathergy reactions. Clin Exp Rheumatol 3(2):137-141 (Pubitemid 15058052)
76. Alpagut U, Ugurlucan M, Dayioglu E (2007) Major arterial involvement and review of Behçet's disease. Ann Vasc Surg 21(2):232-239 (Pubitemid 46367534)
77. Tüzün H, Sayin A, Karaözbek Y, Erdaǧ A, Coskun H, Vural FS (1993) Peripheral aneurysms in Behçet's disease. Cardiovasc Surg 1(3):220-224
78. Tüzün H, Besirli K, Sayin A, Vural FS, Hamuryudan V, Hizli N, Yurdakul S, Yazici H (1997) Management of aneurysms in Behçet's syndrome: an analysis of 24 patients. Surgery 121(2):150-156 (Pubitemid 27091769)
79. Yalcindag FN, Batioglu F (2008) Pathergy-like reaction following intravitreal triamcinolone acetonide injection in a patient with Behçet's disease. Ocul Immunol Inflamm 16(4):181-183
80. Choi IJ, Kim JS, Cha SD, Jung HC, Park JG, Song IS, Kim CY (2000) Long-term clinical course and prognostic factors in intestinal Behçet's disease. Dis Colon Rectum 43(5):692-700 (Pubitemid 30324610)
81. Mat MC, Nazarbaghi M, Tüzün Y, Hamuryudan V, Hizli N, Yurdakul S, Özyazgan Y, Yazici H (1998) Wound healing in Behçet's syndrome. Int J Dermatol 37:120-123
82. Ozarmagan G, Saylan T, Azizlerli G, Ovül C, Aksungur VL (1991) Re-evaluation of the pathergy test in Behçet's disease. Acta Derm Venereol 71(1):75-76
83. Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gül A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52:823-825 (Pubitemid 23328696)
84. Fresko I, Yazici H, Bayramicli M, Yurdakul S, Mat C (1993) Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet's syndrome. Ann Rheum Dis 52:619-620 (Pubitemid 23246670)
85. Fresko I, Ozsoy Y, Mat C, Melikoglu M, Tunc R, Yazici H (2000) The response to the intradermal injection to monosodium urate in Behçet's syndrome and its comparison to the pathergy test. Yonsei Med J 41(3):S25
86. Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfeld P (1995) Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol 132:901-907
87. Melikoglu M, Uysal S, Krueger JG, Kaplan G, Gogus F, Yazici H, Oliver S (2006) Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers. J Immunol 177:6415-6421 (Pubitemid 44628860)
88. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H (2004) Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease. Arthritis Rheum 50:2291-2295 (Pubitemid 38924408)
89. Jorizzo JL, Solomon AR, Cavallo T (1985) Behçet's syndrome. Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up. Arch Pathol Lab Med 109:747-751 (Pubitemid 16237472)
90. Gilhar A, Winterstein G, Turani H, Landau J, Etzioni A (1989) Skin hyperreactivity response (pathergy) in Behçet's disease. J Am Acad Dermatol 21:547-552 (Pubitemid 19221201)
91. Haim S, Sobel JD, Friedman-Birnbaum R, Lichtig C (1976) Histological and direct immunofluorescence study of cutaneous hyperreactivity in Behçet's disease. Br J Dermatol 95:631-636 (Pubitemid 8012162)
92. Gilhar A, Haim S, Wolf V, Golan D (1983) Mast cells in Behçet's disease: ultrastructural and histamine content studies. J Dermatol 10:185-186
93. Budak-Alpdogan T, Demircay Z, Alpdogan O, Direskeneli H, Ergun T, Bayik M, Akoglu T (1997) Skin hyperreactivity of Behçet's patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Ann Haematol 74:45-48
94. Tascilar K, Baran A, Melikoglu M, Gogus F, Hatemi G, Yazici H (2008) Effect of immunosuppressive treatment on skin pathergy reaction in Behçet's syndrome. Clin Exp Rheumatol 26(4):30
95. Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yazici H (2005) Short-term trial of etanercept in Behçet's disease: a double blind, placebo controlled study. J Rheumatol 32:98-105 (Pubitemid 40092599)
96. Jorizzo JL, Taylor RS, Schmalstieg FC, Solomon AR Jr, Daniels JC, Rudloff HE, Cavallo T (1985) Complex aphthosis: a forme fruste of Behçet's syndrome? J Am Acad Dermatol 13(1):80-84 (Pubitemid 15068683)
97. Keogan MT (2009) Clinical immunology review series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome. Clin Exp Immunol 156(1):1-11
98. Rogers RS III (2009) Pseudo-Behçet's disease. Clin Exp Immunol 156(1):1-11
99. Hatemi I, Hatemi G, Celik AF, Melikoglu M, Arzuhal N, Mat C, Ozyazgan Y, Yazici H (2008) Frequency of pathergy phenomenon and other features of Behçet's syndrome among patients with inflammatory bowel disease. Clin Exp Rheumatol 26:S91-S95
100. Tunc R, Uluhan A, Melikoglu M, Ozyazgan Y, Ozdogan H, Yazici H (2001) A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clin Exp Rheumatol 19(5 Suppl 24):S45-S47 (Pubitemid 33730227)
101. Jonsson R, Heyden G, Westberg NG, Nyberg G (1984) Oral mucosal lesions in systemic lupus erythematosus-a clinical, histopathological and immunopathological study. J Rheumatol 11(1):38-42 (Pubitemid 14172139)
102. Fresko I, Yazici H, Isci H, Yurdakul S (1993) Genital ulceration in patients with systemic lupus erythematosus. Lupus 2(2):135
103. Gül A (2005) Behçet's disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4(1):81-83
104. Alpsoy E, Er H, Durusoy C, Yilmaz E (1999) The use of sucralfate suspension in the treatment of oral and genital ulceration of Behçet's disease: a randomized, placebo-controlled, double-blind study. Arch Dermatol 135:529-532 (Pubitemid 29222295)
105. Mumcu G, Ergun T, Elbir Y et al (2005) Clinical and immunological effects of azithromycin in Behçet's disease. J Oral Pathol Med 34:13-16 (Pubitemid 40142924)
106. Hamuryudan V, Yurdakul S, Serdaroglu S, Tuzun Y, Rosenkaimer F, Yazici H (1990) Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a preliminary report. Clin Exp Rheumatol 8:51-54 (Pubitemid 20158227)
107. Ergun T, Gurbuz O, Yurdakul S, Hamuryudan V, Bekiroglu N, Yazici H (1997) Topical cyclosporine-A for treatment of oral ulcers of Behçet's syndrome. Int J Dermatol 36:720 (Pubitemid 27452162)
108. Mat C, Tuzun T, Ozsoy Y, Erturk G, Mercan E, Fresko I, Baykal IE, Araman A, Yazici H (2000) Cromolyn gel 4%in the treatment of genital ulcers of Behçet's disease. In: Bang D, Lee ES, Lee S (eds) Proceeding of the International Conference on Behçet's disease, Seoul, p 907
109. Tasli L, Mat C, De Simone C, Yazici H (2006) Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome. Clin Exp Rheumatol 24:S83-S86 (Pubitemid 44696884)